GPR17 may contribute to neuronal damage and cognitive impairments by regulating the NF-κB p65/CREB/BDNF(cAMP response element-binding protein/brain-derived neurotrophic factor) signaling pathway, thus promoting the expression of oxidative stress and inflammatory factors (Liang et al., 2023). The gene discussed is BDNF; the disease is Cognitive impairment.